Spots Global Cancer Trial Database for disease management
Every month we try and update this database with for disease management cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| European Registry for Myeloproliferative Neoplasms (MPNs) - Update of ERNEST Study | NCT04153305 | Myelofibrosis | 18 Years - | FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS | ||
| Evaluation of Programs of Coordinated Care and Disease Management | NCT00627029 | Congestive Hear... Diabetes Coronary Artery... Chronic Obstruc... Cancer Cerebrovascular... Alzheimer's Dis... Psychotic Disor... Major Depressio... | Care Coordinati... | - | Mathematica Policy Research, Inc. | |
| A Study for the Treatment of Unresectable Stage III or Metastatic Stage IV Melanoma | NCT00281541 | Melanoma | YM155 | 18 Years - | Astellas Pharma Inc | |
| Evaluation of Programs of Coordinated Care and Disease Management | NCT00627029 | Congestive Hear... Diabetes Coronary Artery... Chronic Obstruc... Cancer Cerebrovascular... Alzheimer's Dis... Psychotic Disor... Major Depressio... | Care Coordinati... | - | Mathematica Policy Research, Inc. | |
| Management of Prostate Cancer in Central China | NCT01614548 | Prostate Cancer | - | Zhengzhou University | ||
| A Study for the Treatment of Hormone Refractory Prostate Cancer (HRPC) in Patients Previously Treated With Chemotherapy | NCT00257478 | Prostate Cancer Cancer of Prost... Prostatic Cance... Cancer of the P... | YM155 | 18 Years - | Astellas Pharma Inc | |
| LUCY: A Study for the Treatment of Non-Small Cell Lung Cancer (NSCLC) in Patients Previously Treated With Chemotherapy | NCT00328588 | Lung Cancer Cancer of Lung Cancer of the L... Non-Small Cell ... Carcinoma, Non-... | YM155 | 18 Years - | Astellas Pharma Inc | |
| Evaluation of Medical Treatments in MBC Patients According Biological Subtype and Line of Treatments | NCT02284581 | Metastatic Brea... | 18 Years - | Consorzio Oncotech | ||
| Evaluation of Medical Treatments in MBC Patients According Biological Subtype and Line of Treatments | NCT02284581 | Metastatic Brea... | 18 Years - | Consorzio Oncotech | ||
| Evaluation of Programs of Coordinated Care and Disease Management | NCT00627029 | Congestive Hear... Diabetes Coronary Artery... Chronic Obstruc... Cancer Cerebrovascular... Alzheimer's Dis... Psychotic Disor... Major Depressio... | Care Coordinati... | - | Mathematica Policy Research, Inc. | |
| Evaluation of Medical Treatments in MBC Patients According Biological Subtype and Line of Treatments | NCT02284581 | Metastatic Brea... | 18 Years - | Consorzio Oncotech | ||
| A Study for the Treatment of Unresectable Stage III or Metastatic Stage IV Melanoma | NCT00281541 | Melanoma | YM155 | 18 Years - | Astellas Pharma Inc | |
| Evaluation of Medical Treatments in MBC Patients According Biological Subtype and Line of Treatments | NCT02284581 | Metastatic Brea... | 18 Years - | Consorzio Oncotech |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
